Document Detail

Management of hematological malignancies during pregnancy.
MedLine Citation:
PMID:  19844988     Owner:  NLM     Status:  MEDLINE    
The management of hematological malignancies during pregnancy is a challenging endeavor, which not only requires technical skills and knowledge by the clinicians but also requires sound clinical judgment and compassion, keeping in mind the patient and family preferences and, ultimately, the wellbeing of the neonate. The incidence of hematological malignancies during pregnancy is rare, ranging from 1 in 1,000 to 1 in 10,000 deliveries, impeding the design and execution of large prospective studies. The purpose of this review is to evaluate the limited existing data and make useful suggestions in the management of acute and chronic leukemias, Hodgkin and non-Hodgkin lymphomas, plasma cell myeloma, and other hematological malignancies, such as myelodysplastic syndromes and hairy cell leukemia, during pregnancy.
Tina Rizack; Anthony Mega; Robert Legare; Jorge Castillo
Related Documents :
24628488 - Understanding the effects of mtv's 16 and pregnant on adolescent girls' beliefs, attitu...
15912178 - Management strategy for meningioma in pregnancy: a clinical study.
3167588 - Burns during pregnancy: our experience.
18295858 - Spinal cord compression caused by vertebral hemangioma being symptomatic during pregnancy.
24082648 - Preimplantation and postimplantation therapy for the treatment of reproductive failure.
16405518 - Diagnosis of deep vein thrombosis and pulmonary embolism in pregnancy: a systematic rev...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  American journal of hematology     Volume:  84     ISSN:  1096-8652     ISO Abbreviation:  Am. J. Hematol.     Publication Date:  2009 Dec 
Date Detail:
Created Date:  2009-11-30     Completed Date:  2009-12-04     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7610369     Medline TA:  Am J Hematol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  830-41     Citation Subset:  IM    
Copyright Information:
(c) 2009 Wiley-Liss, Inc.
Division of Hematology and Oncology, The Miriam Hospital, The Warren Alpert Medical School of Brown University, Providence, Rhode Island 02906, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Abnormalities, Drug-Induced / etiology,  prevention & control
Abortion, Induced
Antiemetics / therapeutic use
Antineoplastic Agents / administration & dosage,  adverse effects,  contraindications,  therapeutic use
Cesarean Section
Clinical Protocols
Combined Modality Therapy
Disease Management
Hematologic Neoplasms / drug therapy*,  epidemiology,  therapy
Infant, Newborn
Infant, Newborn, Diseases / chemically induced,  prevention & control
Pregnancy Complications, Hematologic / drug therapy*,  epidemiology,  therapy
Pregnancy Complications, Neoplastic / drug therapy*,  epidemiology,  therapy
Pregnancy Outcome
Pregnancy Trimesters
Reg. No./Substance:
0/Antiemetics; 0/Antineoplastic Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Prodromal myeloproliferative neoplasms: the 2008 WHO classification.
Next Document:  Identification of molecular targets associated with transformed diffuse large B cell lymphoma using ...